As Signum Surgical pursues broader commercialization to increase patient access to the FDA De Novo-authorized BioHealx® Anal Fistula Device, it is continuing to expand the clinical evidence supporting BioHealx Assisted Fistula Treatment (BAFT™). An ongoing multicenter post-market clinical study is
Clinical evidence is an important part of evaluating any new approach to anal fistula treatment. The BioHealx® Anal Fistula Device was evaluated in a prospective, multicenter first-in-human clinical study designed to assess its safety and effectiveness in treating cryptoglandular transsphincteric
Anal fistula repair remains a challenging problem. Existing surgical procedures include fistulotomy with or without sphincter repair, LIFT, endoanal flap and plugs. Reported failure rates for these traditional anal fistula procedures range from 30–70%.1,2 Many papers have been published over
What is an Anal Fistula? An anal fistula is a small tunnel that develops between the inside of the anus or rectum and the skin near the anus. It most often forms after an anal abscess (a pocket of infection)
This coding and reimbursement resource is intended for healthcare providers and their billing and coding teams. Coding and Reimbursement Information The table below includes examples of codes that may be applicable when billing for the treatment of transsphincteric fistulas and
The information below seeks to combat common misconceptions and provide patients with a basic understanding of options for fistula treatment. For patients with an anal fistula, it is important to see a specialist. A colorectal surgeon or general surgeon experienced
Philadelphia, PA – iHeartRadio Interviews Dr. Philip Pearson about Anal Fistula and BioHealx In an episode of What’s Going On, Loraine Ballard Morrill speaks with Dr. Philip Pearson, colorectal surgeon, educator, and social media personality known as the “Singing Surgeon,”
Please get in touch with us using this form.
"*" indicates required fields
